Can Vitamin C Prevent and Treat COVID-19? Insights from Pharmacists

Can Vitamin C Prevent and Treat COVID-19? Insights from Pharmacists

According to a report from Health Times on February 14, the team led by Professor Peng Zhiyong at Zhongnan Hospital of Wuhan University is conducting clinical trials on high-dose Vitamin C treatment for COVID-19, suggesting that Vitamin C may be used for treating COVID-19. Professor Peng Zhiyong explained that the dosage of Vitamin C used … Read more

Potential Efficacy of High-Dose Vitamin C in Terminal Cancer Treatment

Potential Efficacy of High-Dose Vitamin C in Terminal Cancer Treatment

Medical researchers are not only continuously developing new anti-tumor drugs but are also trying to find new uses for old drugs, hoping to alleviate the suffering caused by cancer and extend survival. High-dose vitamin C treatment for cancer is one of these methods, which is still under research. Many people may wonder how vitamin C, … Read more

Clinical Practice and Research Progress of Artificial Liver Treatment

Clinical Practice and Research Progress of Artificial Liver Treatment

Hepatic failure is a common critical condition caused by severe liver dysfunction, particularly acute (subacute) liver failure and subacute liver failure, which progress rapidly and have a high mortality rate. The basic principle of the artificial liver support system is to temporarily replace part of the liver’s function through extracorporeal mechanical, physicochemical, and biological devices, … Read more

Lessons Learned in ADC Clinical Development

Lessons Learned in ADC Clinical Development

Introduction Antibody-drug conjugates (ADC) are formed by linking monoclonal antibodies targeting specific antigens with small molecule cytotoxic drugs through linkers, combining the powerful killing effect of traditional small molecule chemotherapy with the tumor targeting ability of antibody drugs. Since ADCs first entered clinical trials in the mid-1990s, they have developed into a very successful oncology … Read more

Hengrui SHR-A1811: Soaring Higher on the Shoulders of DS-8201

Hengrui SHR-A1811: Soaring Higher on the Shoulders of DS-8201

Focused and dedicated, stepping onto the international stage Written by|Little Medicine Monster The latest generation of anti-HER-2 ADC drug developed by Hengrui, SHR-A1811, is often jokingly referred to as the domestic alternative to DS-8201 due to its similar structure. However, strength will eliminate all rumors. Results from early clinical studies released by AACR this year … Read more